Yesterday, Bernie Sanders slammed Eli Lilly stock after the former presidential candidate and Vermont Senator asked “why has the price of Humalog insulin gone up 700% in 20 years? It’s simple. The drug industry’s greed”, sending LLY stock to 7 month lows.
Today Bernie’s vendetta with the pharma industry was in the spotlight again, when moments ago Sanders tweeted that “the business model of the drug industry is fraud. Glaxo put patients at risk to increase their profits”
The business model of the drug industry is fraud. Glaxo put patients at risk to increase their profits. https://t.co/sj5OIUxC8N
— Bernie Sanders (@SenSanders) November 2, 2016
In kneejerk reaction, the ADRs of Glaxo stock immediately slid to session lows as yet another shot across the bow of the pharma industry was launched by the prominent democrat.